China Vaccine Sector Steams To COVID Finish Line Despite Scandal-Ridden Past
When a high-profile regulatory official in China was sentenced to 10 years in prison, at least five vaccine makers were found to have paid millions in bribes, although none were rigorously prosecuted. Three years later, as the country gears up for worldwide roll-out of its COVID-19 vaccines, many wonder if there are haunting glimmers from the past.
You may also be interested in...
A WHO team concludes a high-profile investigation in Wuhan, where the first coronavirus cases surfaced over a year ago, while a single-dose vaccine from China's CanSino is on the way.
China's largest physician portal DXY has been banned from posting on a major social media platform after naming a new zoonotic virus after the place where it originated.
While new legislation has pushed prescription drug pricing high up the political agenda for US lawmakers, the issue has also come into the spotlight again for Chinese regulators, which have just launched new investigations into two officials. While the two countries are taking drastically different routes to tackling pricing, the developments show compliance risks remain high in China.